Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07135687) titled 'Study to Use Oral Losartan to Decrease the Risk of Postoperative Scarring Following (ACL) Reconstruction' on Aug. 14.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Other. Masking: Double (Participant, Investigator).
Primary Sponsor: Rush University Medical Center
Condition:
ACL Injury
ACL Reconstruction
Scar Formation
Intervention:
Drug: Losartan
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: October 2025
Target Sample Size: 144
Countries of Recruitment:
United States
To know more, visit https://clini...